RheumaConnect Application icon

RheumaConnect 1.2.1

21.5 MB / 1+ Downloads / Rating 3.5 - 2 reviews


See previous versions

RheumaConnect, developed and published by Merck Sharp & Dohme Corp, has released its latest version, 1.2.1, on 2018-08-16. This app falls under the Medical category on the Google Play Store and has achieved over 50 installs. It currently holds an overall rating of 3.5, based on 2 reviews.

RheumaConnect APK available on this page is compatible with all Android devices that meet the required specifications (Android 4.0+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: air.com.merck.RheumaConnect

Updated: 6 years ago

Developer Name: Merck Sharp & Dohme Corp

Category: Medical

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing RheumaConnect on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

App Rating

3.5
Total 2 reviews

Previous Versions

RheumaConnect 1.2.1
2018-08-16 / 21.5 MB / Android 4.0+

About this app

The application RheumaConnect has been developed by MSD Belgium and is intended to help patients suffering from rheumatic diseases (RA rheumatoide arthritis, polyarthritis, SA ankylosing spondylitis, Bechterew, axial spondyloarthritis, PsA psoriatic arthritis). Besides a number of interesting tools for the patient (like consultations / medication reminders, links to patient organizations, where they can find useful, and validated info regarding their disease etc.), it can be used to provide the doctor with accurate and structured feedback about the evolution of the disease and its impact on the quality of life of the patient. The app is not intended to replace doctor visits.

The app has the following objectives and functionalities.
• The patient can fill a weekly questionnaire (2 questions).
• The patient can fill a monthly questionnaire with feedback on the impact of the disease on the patient’s quality of life.
• The patient can send this feedback as a report by email to the physician/rheumatologist.
• The patient can receive reminders for medication intake.
• The app provides the patients with links to patient organizations, where they can find useful and validated information regarding the disease.



Privacy disclaimer

MSD Belgium BVBA/SPRL is the Belgian subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, USA, a leading research-based pharmaceutical company that discovers, develops, manufactures and markets a wide range of innovative pharmaceutical products, in order to improve the life of patients in Belgium and around the world.

MSD does its utmost to protect the data in the app to guarantee the privacy of the patient. Data are encrypted on the mobile device and can be accessed only by using the app. The patient will be requested to choose a 4 digit PIN code when installing the app. MSD will not have access to the user data and personal information in the app, nor the app shares data with third parties. The patient can, at his own discretion, send information from the app to the attending physician (or nurse), via email, however, the patient should consider carefully what personal information to provide or what documents to share through a personal mail account. It is recommended to take existing security parameters of e-mail transmission into account, including but not limited to the integrity of the used communication network. The physician receiving the information is responsible for the data privacy and protection.

For additional information about privacy and data protection at MSD, please go to this website: http://www.msd-belgium.be/english/about/how-we-operate/pages/privacy.aspx.

MSD will make use of Google Analytics for statistics on the usage of the application to improve the functionality of the system. No personally identifiable information is used for these statistics, MSD will only have access to aggregated data.

rheuma,polyarthritis,spondyloarthritis,back pain,psoriatic,articular,autoimmune,dactylitis,enthesitis,biological,arthritis,rheuma,connect,rheumaconnect

RHEU-1165207-0000 Date of last revision: 01/2016

New features

Small bug fix

App Permissions

Allows applications to open network sockets.
Allows an application to write to external storage.
Allows applications to access information about networks.
Allows applications to access information about Wi-Fi networks.
Allows an application to write to external storage.
Allows read only access to phone state, including the phone number of the device, current cellular network information, the status of any ongoing calls, and a list of any PhoneAccounts registered on the device.
Allows an application to receive the ACTION_BOOT_COMPLETED that is broadcast after the system finishes booting.
Allows access to the list of accounts in the Accounts Service.
This constant was deprecated in API level 21. No longer enforced.
Allows access to the vibrator.
Allows using PowerManager WakeLocks to keep processor from sleeping or screen from dimming.
Allows an application to read from external storage.